Found: 7
Select item for more details and to access through your institution.
Effects of PCSK9 inhibition on glucose metabolism and β-cell function in humans: a pilot study.
- Published in:
- Frontiers in Endocrinology, 2023, p. 01, doi. 10.3389/fendo.2023.1124116
- By:
- Publication type:
- Article
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3668
- By:
- Publication type:
- Article
Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 1, p. 1, doi. 10.1002/dmrr.3358
- By:
- Publication type:
- Article
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 1, p. 257, doi. 10.1007/s13300-023-01491-5
- By:
- Publication type:
- Article
Prediabetes: how pathophysiology drives potential intervention on a subclinical disease with feared clinical consequences.
- Published in:
- Minerva Endocrinology, 2021, v. 46, n. 3, p. 272, doi. 10.23736/S2724-6507.21.03405-9
- By:
- Publication type:
- Article
Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5936, doi. 10.3390/ijms25115936
- By:
- Publication type:
- Article
Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function.
- Published in:
- Nutrients, 2023, v. 15, n. 19, p. 4202, doi. 10.3390/nu15194202
- By:
- Publication type:
- Article